Sernova Corp. (TSE:SVA – Get Free Report) shares reached a new 52-week low during trading on Monday . The stock traded as low as C$0.12 and last traded at C$0.13, with a volume of 140962 shares changing hands. The stock had previously closed at C$0.14.
Sernova Stock Down 7.4%
The company has a market capitalization of C$41.09 million, a price-to-earnings ratio of -2.50 and a beta of 0.67. The company has a debt-to-equity ratio of -4.40, a quick ratio of 18.11 and a current ratio of 0.32. The business has a 50-day simple moving average of C$0.16 and a two-hundred day simple moving average of C$0.17.
About Sernova
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.
Recommended Stories
- Five stocks we like better than Sernova
- Stock Splits, Do They Really Impact Investors?
- D-Wave: Time to Buy the Dip? Or is the Fall Just Starting?
- Breakout Stocks: What They Are and How to Identify Them
- Hims, Block, and NRG Just Launched Huge Stock Buybacks
- How to Read Stock Charts for Beginners
- Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
